You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅太陽(000525.SZ):預計四大子公司84消毒液系列消毒產品產能約10萬噸/年
格隆匯 02-20 09:16

格隆匯2月20日丨紅太陽(000525.SZ)公佈,目前,安徽瑞邦已經獲得安徽省衞生健康委員會頒發的《消毒產品生產企業衞生許可證》,南京生化、重慶中邦、山東科信的衞生許可證正在辦理中,將加快取得許可後投入正常生產經營。

此次安徽瑞邦、南京生化、重慶中邦、山東科信以生產、經營市場急需的84消毒液系列消毒產品業務,主要利用現有裝置、設備和廠房,不涉及重大投資。預計全部投產後合計產能約為10萬噸/年。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account